Intas Pharmaceuticals Limited is an Indian multinational pharmaceutical company with manufacturing facilities in India, the UK, and Mexico. Their manufacturing capabilities include: 

• Facilities

  Intas has 14 formulation manufacturing facilities, 2 API and intermediate manufacturing facilities, and an oncology formulation facility. 

• Products

  Intas manufactures active pharmaceutical ingredients (API), oral solid dose (OSD), injectables, biosimilars, and plasma products. 

• Regulatory compliance

  Intas' facilities comply with regulatory requirements and have received approvals from international regulatory bodies such as the U.S. Food and Drug Administration (FDA). 

• Manufacturing capabilities

  Intas' facilities are designed to deliver high-quality products within defined cost and delivery schedules. 

• Manufacturing strategy

  Intas is focusing on indigenous manufacturing of critical products and is boosting manufacturing capabilities. 

• Research and development

  Intas contributes to science through the development of new technology. 

• Audits and inspections

  Intas' facilities are subject to audits and inspections from international regulatory authorities such as the FDA, MHRA, EMA, ANVISA, SAHPRA, GCC, TGA, T.C. Sağlık Bakanlığı, AEMPS, and ANMAT. 

Intas' corporate office is located at Corporate House, Near Sola Bridge, S. G. Highway, Thaltej, Ahmedabad – 380054.